CN102659763A - 一种右旋兰索拉唑合成与纯化的方法 - Google Patents
一种右旋兰索拉唑合成与纯化的方法 Download PDFInfo
- Publication number
- CN102659763A CN102659763A CN2012101303411A CN201210130341A CN102659763A CN 102659763 A CN102659763 A CN 102659763A CN 2012101303411 A CN2012101303411 A CN 2012101303411A CN 201210130341 A CN201210130341 A CN 201210130341A CN 102659763 A CN102659763 A CN 102659763A
- Authority
- CN
- China
- Prior art keywords
- dextrorotation
- lansoprazole
- preparing
- temperature
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 38
- MJIHNNLFOKEZEW-RUZDIDTESA-N dexlansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-RUZDIDTESA-N 0.000 title abstract description 7
- 229960003568 dexlansoprazole Drugs 0.000 title abstract description 7
- 230000002194 synthesizing effect Effects 0.000 title abstract 2
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 claims description 52
- 229960003174 lansoprazole Drugs 0.000 claims description 51
- 239000007787 solid Substances 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 20
- 238000001816 cooling Methods 0.000 claims description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 10
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 230000003197 catalytic effect Effects 0.000 claims description 6
- YSAVZVORKRDODB-PHDIDXHHSA-N diethyl (2r,3r)-2,3-dihydroxybutanedioate Chemical compound CCOC(=O)[C@H](O)[C@@H](O)C(=O)OCC YSAVZVORKRDODB-PHDIDXHHSA-N 0.000 claims description 6
- 239000012044 organic layer Substances 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000003495 polar organic solvent Substances 0.000 claims description 4
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 3
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 3
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 claims description 3
- 150000003851 azoles Chemical class 0.000 claims description 2
- 239000012043 crude product Substances 0.000 claims description 2
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 2
- 235000015320 potassium carbonate Nutrition 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 14
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000010907 mechanical stirring Methods 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 4
- 239000012065 filter cake Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 230000006340 racemization Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000000967 suction filtration Methods 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 230000027119 gastric acid secretion Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- MJIHNNLFOKEZEW-VWLOTQADSA-N 2-[(s)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1h-benzimidazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1C[S@](=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-VWLOTQADSA-N 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 101000870046 Sus scrofa Glutamate dehydrogenase 1, mitochondrial Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- YVTOMMZSPPOQIU-UHFFFAOYSA-N [Cl-]C1=C(CSc2nc(cccc3)c3[nH]2)N=CCC1OCCl Chemical compound [Cl-]C1=C(CSc2nc(cccc3)c3[nH]2)N=CCC1OCCl YVTOMMZSPPOQIU-UHFFFAOYSA-N 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210130341.1A CN102659763B (zh) | 2012-04-27 | 2012-04-27 | 一种右旋兰索拉唑合成与纯化的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210130341.1A CN102659763B (zh) | 2012-04-27 | 2012-04-27 | 一种右旋兰索拉唑合成与纯化的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102659763A true CN102659763A (zh) | 2012-09-12 |
CN102659763B CN102659763B (zh) | 2014-01-22 |
Family
ID=46769372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210130341.1A Active CN102659763B (zh) | 2012-04-27 | 2012-04-27 | 一种右旋兰索拉唑合成与纯化的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102659763B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103961322A (zh) * | 2013-02-05 | 2014-08-06 | 辽宁海思科制药有限公司 | 一种注射用右旋兰索拉唑冻干组合物及其制备方法 |
CN104003930A (zh) * | 2014-06-13 | 2014-08-27 | 山东阿如拉药物研究开发有限公司 | 一种盐酸罗哌卡因的制备方法 |
CN105017216A (zh) * | 2014-04-16 | 2015-11-04 | 天津药物研究院 | 右兰索拉唑晶型iii及其制备方法和用途 |
CN105218391A (zh) * | 2015-07-09 | 2016-01-06 | 天津青松华药医药有限公司 | D-酒石酸单酯单酰胺类化合物 |
CN107141280A (zh) * | 2017-07-10 | 2017-09-08 | 长沙康普大药房有限责任公司 | 一种右旋兰索拉唑的制备方法 |
CN107400119A (zh) * | 2017-08-29 | 2017-11-28 | 珠海赛隆药业股份有限公司 | 一种右旋兰索拉唑的制备方法 |
CN108440501A (zh) * | 2018-04-19 | 2018-08-24 | 湖北省医药工业研究院有限公司 | 质子泵抑制剂右兰索拉唑的制备方法 |
CN110156753A (zh) * | 2019-05-31 | 2019-08-23 | 北京四环制药有限公司 | 一种稳定的高纯度右旋兰索拉唑及其制备方法 |
CN110204531A (zh) * | 2019-05-31 | 2019-09-06 | 北京四环制药有限公司 | 一种稳定的高纯度右旋兰索拉唑及其制备方法 |
CN114163419A (zh) * | 2021-12-24 | 2022-03-11 | 辰欣药业股份有限公司 | 一种兰索拉唑的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1157614A (zh) * | 1994-07-15 | 1997-08-20 | 阿斯特拉公司 | 取代的亚砜类化合物的合成方法 |
CN1919844A (zh) * | 2006-09-01 | 2007-02-28 | 武汉工程大学 | 水相氧化合成兰索拉唑的方法 |
WO2010095144A2 (en) * | 2009-02-04 | 2010-08-26 | Msn Laboratories Limited | Process for the preparation of proton pump inhibitors |
WO2011121548A1 (en) * | 2010-03-31 | 2011-10-06 | Ranbaxy Laboratories Limited | Process for the preparation of dexlansoprazole |
-
2012
- 2012-04-27 CN CN201210130341.1A patent/CN102659763B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1157614A (zh) * | 1994-07-15 | 1997-08-20 | 阿斯特拉公司 | 取代的亚砜类化合物的合成方法 |
CN1919844A (zh) * | 2006-09-01 | 2007-02-28 | 武汉工程大学 | 水相氧化合成兰索拉唑的方法 |
WO2010095144A2 (en) * | 2009-02-04 | 2010-08-26 | Msn Laboratories Limited | Process for the preparation of proton pump inhibitors |
WO2011121548A1 (en) * | 2010-03-31 | 2011-10-06 | Ranbaxy Laboratories Limited | Process for the preparation of dexlansoprazole |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103961322B (zh) * | 2013-02-05 | 2019-01-08 | 辽宁海思科制药有限公司 | 一种注射用右旋兰索拉唑冻干组合物及其制备方法 |
CN103961322A (zh) * | 2013-02-05 | 2014-08-06 | 辽宁海思科制药有限公司 | 一种注射用右旋兰索拉唑冻干组合物及其制备方法 |
CN105017216A (zh) * | 2014-04-16 | 2015-11-04 | 天津药物研究院 | 右兰索拉唑晶型iii及其制备方法和用途 |
CN104003930A (zh) * | 2014-06-13 | 2014-08-27 | 山东阿如拉药物研究开发有限公司 | 一种盐酸罗哌卡因的制备方法 |
CN104003930B (zh) * | 2014-06-13 | 2016-06-08 | 山东金诃药物研究开发有限公司 | 一种盐酸罗哌卡因的制备方法 |
CN105218391A (zh) * | 2015-07-09 | 2016-01-06 | 天津青松华药医药有限公司 | D-酒石酸单酯单酰胺类化合物 |
CN105218391B (zh) * | 2015-07-09 | 2017-11-21 | 天津青松华药医药有限公司 | L‑酒石酸单酯单酰胺类化合物 |
CN107141280A (zh) * | 2017-07-10 | 2017-09-08 | 长沙康普大药房有限责任公司 | 一种右旋兰索拉唑的制备方法 |
CN107400119A (zh) * | 2017-08-29 | 2017-11-28 | 珠海赛隆药业股份有限公司 | 一种右旋兰索拉唑的制备方法 |
CN108440501A (zh) * | 2018-04-19 | 2018-08-24 | 湖北省医药工业研究院有限公司 | 质子泵抑制剂右兰索拉唑的制备方法 |
CN110156753A (zh) * | 2019-05-31 | 2019-08-23 | 北京四环制药有限公司 | 一种稳定的高纯度右旋兰索拉唑及其制备方法 |
CN110204531A (zh) * | 2019-05-31 | 2019-09-06 | 北京四环制药有限公司 | 一种稳定的高纯度右旋兰索拉唑及其制备方法 |
CN114163419A (zh) * | 2021-12-24 | 2022-03-11 | 辰欣药业股份有限公司 | 一种兰索拉唑的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102659763B (zh) | 2014-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102659763B (zh) | 一种右旋兰索拉唑合成与纯化的方法 | |
CN102584792A (zh) | 制备高纯度的埃索美拉唑盐的方法 | |
KR101062806B1 (ko) | 광학적으로 순수한 활성 화합물의 제조 방법 | |
CN103044402B (zh) | 埃索美拉唑钠合成生产方法 | |
EA009385B1 (ru) | Способ энантиоселективного синтеза отдельных энантиомеров модафинила асиметричным окислением | |
CN101429192A (zh) | 生产手性亚砜衍生物的新方法 | |
CN103936714A (zh) | 一种埃索美拉唑镁的制备方法 | |
CN102906074A (zh) | 稠合咪唑衍生物 | |
CN104177336A (zh) | 一种对映选择性合成右兰索拉唑的方法 | |
CN105732605A (zh) | 一种艾沙康唑中间体的制备方法 | |
KR101169471B1 (ko) | (s)-판토프라졸의 제조 방법 | |
CN1337947A (zh) | 炔基磺酰胺硫醇tace抑制剂 | |
CN103833731B (zh) | 手性亚砜类化合物及其盐的制备新方法和晶型 | |
CN102010327B (zh) | (±)-2-(3-苯甲酰基)-苯基丙酸的拆分方法 | |
CN104387368A (zh) | 一种右兰索拉唑的制备方法 | |
CN101323609B (zh) | 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法 | |
CN110467580A (zh) | 雷西纳德轴手性对映体的拆分方法 | |
CN112513011B (zh) | 苯衍生物 | |
CN102432412A (zh) | 一种手性亚砜类质子泵抑制剂或其可药用盐的制备方法 | |
CN103131747A (zh) | 利用生物酶手性拆分合成(s)-3-(4-羟基苯基)-3-甲氨基丙酸的方法 | |
CN106632053B (zh) | 一种盐酸右美托咪定中间体的拆分方法 | |
CN106749030B (zh) | 一种用于icu镇静镇痛的盐酸右美托咪定的制备方法 | |
JP6325178B2 (ja) | エソメプラゾールの光学精製の改良された方法 | |
CN103992306B (zh) | 一种左旋泮托拉唑钠的制备及精制方法 | |
CN108440501A (zh) | 质子泵抑制剂右兰索拉唑的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 210046 Nanjing economic and Technological Development Zone, Jiangsu Heng Road, No. 28 Applicant after: NANJING YOKO BIOMEDICAL R & D Ltd. Applicant after: NANJING YOKO PHARMACEUTICAL Co.,Ltd. Address before: 210046 Nanjing economic and Technological Development Zone, Jiangsu Heng Road, No. 28 Applicant before: NANJING YOKO BIOMEDICAL R & D Ltd. Applicant before: NANJING YOKO PHARMACEUTICAL Co.,Ltd. Applicant before: NANJING XINGANG MEDICAL Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 210046 Nanjing economic and Technological Development Zone, Jiangsu Heng Road, No. 28 Patentee after: NANJING YOKO BIOMEDICAL R & D Ltd. Patentee after: NANJING YOKO BIOLOGICAL PHARMACEUTICAL GROUP Co.,Ltd. Patentee after: NANJING YOKO PHARMACEUTICAL Co.,Ltd. Address before: 210046 Nanjing economic and Technological Development Zone, Jiangsu Heng Road, No. 28 Patentee before: NANJING YOKO BIOMEDICAL R & D Ltd. Patentee before: Nanjing uniclever biological pharmaceutical Limited by Share Ltd. Patentee before: NANJING YOKO PHARMACEUTICAL Co.,Ltd. Address after: 210046 Nanjing economic and Technological Development Zone, Jiangsu Heng Road, No. 28 Patentee after: NANJING YOKO BIOMEDICAL R & D Ltd. Patentee after: Nanjing uniclever biological pharmaceutical Limited by Share Ltd. Patentee after: NANJING YOKO PHARMACEUTICAL Co.,Ltd. Address before: 210046 Nanjing economic and Technological Development Zone, Jiangsu Heng Road, No. 28 Patentee before: NANJING YOKO BIOMEDICAL R & D Ltd. Patentee before: NANJING YOKO PHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 210046 No. 28, Heng Jing Road, Nanjing economic and Technological Development Zone, Jiangsu, China Co-patentee after: Nanjing uniclever biological pharmaceutical Limited by Share Ltd. Patentee after: NANJING YOKO BIOMEDICAL R & D Ltd. Co-patentee after: NANJING YOKO PHARMACEUTICAL Co.,Ltd. Address before: 210046 No. 28, Heng Jing Road, Nanjing economic and Technological Development Zone, Jiangsu, China Co-patentee before: NANJING YOKO BIOLOGICAL PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: NANJING YOKO BIOMEDICAL R & D Ltd. Co-patentee before: NANJING YOKO PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200630 Address after: Room 310, science and technology innovation base, No.3 Hengda Road, Nanjing Economic and Technological Development Zone, Nanjing, Jiangsu Province Patentee after: Nanjing spark Pharmaceutical Technology Co.,Ltd. Address before: 210046 No. 28, Heng Jing Road, Nanjing economic and Technological Development Zone, Jiangsu, China Co-patentee before: Nanjing uniclever biological pharmaceutical Limited by Share Ltd. Patentee before: NANJING YOKO BIOMEDICAL R & D Ltd. Co-patentee before: NANJING YOKO PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230406 Address after: No. 5-1 Jianshe Road, Nanjing Economic and Technological Development Zone, Jiangsu Province, 210000 Patentee after: Nanjing Bode Biopharmaceutical Co.,Ltd. Address before: 210000 room 310, science and innovation base, No.3 Hengda Road, Nanjing Economic and Technological Development Zone, Nanjing City, Jiangsu Province Patentee before: Nanjing spark Pharmaceutical Technology Co.,Ltd. |